Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are more accurate than general practitioners in diagnosing skin conditions, especially skin cancer.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Stem cell therapy may help treat tough hair loss cases.

Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Mutations in the WNT10A gene can cause skin, hair, teeth, and other disorders, and may also affect other areas like kidney and cancer, with potential for targeted treatments.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Using defensins to activate stem cells may improve skin aging signs without causing inflammation.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Platelet-rich plasma might help with skin aging, ulcers, and hair loss, but more research is needed to prove its effectiveness and safety.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Almost half of the men with beard hair loss also developed scalp hair loss within a year.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Traditional and complementary medicine may help with skin conditions, but more high-quality research is needed.

Platelet-rich plasma (PRP) may help promote hair growth and improve graft survival after hair transplantation, but more research is needed to confirm its effectiveness and determine the best dosage.

Doctors should consider psychological factors when treating skin conditions and work with mental health experts.

The document concludes that mesotherapy can be effective for skin and hair treatments, but more research is needed to confirm its safety and effectiveness.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Betamethasone can effectively treat alopecia areata.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Home-based skin care devices are generally safe and effective for hair removal, promoting hair growth, treating wrinkles and acne, but results for psoriasis treatment are mixed.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.